MRS Meetings and Events

 

NM04.13.03 2022 MRS Spring Meeting

Iron Oxide and Various Metal Oxide Hollow Nanoparticles Engineered by One-Pot Double Galvanic Replacement Reaction and the Application for Anti-Cancer Therapy

When and Where

May 25, 2022
9:00am - 9:15am

NM04-Virtual

Presenter

Co-Author(s)

Aloka Paragodaarachchi1,2,Steven Medvedovsky2,Justin Fang1,2,Min Kang1,2,Hiroshi Matsui1,2,3

City University of New York1,Hunter College2,Weill Cornell Medical College3

Abstract

Aloka Paragodaarachchi1,2,Steven Medvedovsky2,Justin Fang1,2,Min Kang1,2,Hiroshi Matsui1,2,3

City University of New York1,Hunter College2,Weill Cornell Medical College3
Although freestanding hollow one-dimensional metal oxide nanoparticles represent an intriguing class of nanomaterials, their practical application has been hampered by complex and expensive synthesis protocols. Here, a new one-pot double Galvanic approach that is both simple and economical is developed for the synthesis of hollow one-dimensional iron oxide nanotubes. In the initial reaction, nanowire substrate (Ag) is oxidized by MnO<sub>4</sub><sup>-</sup> ions to form an intermediate nanotube substrate (Mn<sub>3</sub>O<sub>4</sub>), which is then reduced by Fe<sup>2+</sup> ions to form an Fe<sub>2</sub>O<sub>3</sub> nanotube product. Mn<sub>3</sub>O<sub>4</sub> intermediate aid to expand the scope of the reaction for various metal oxides. To test the generality of this approach, the synthesis of SnO<sub>2</sub>, CuO, and NiO<sub>2</sub> nanotubes is also examined. Thus, this method could offer robust, economical, and scale-up engineering to generate a variety of metal oxide nanotubes based on the reduction potential hierarchy. As proof-of-principle for the application of these hollow iron-oxide nanoparticles for cancer therapy we have successfully synthesized iron oxide nanoparticle with a characteristic cage shape (IO-NC) using the Galvanic replacement reaction starting from manganese oxide nano cube. We have demonstrated that the cavity of the IO-NC can hold anticancer drugs/RNA molecules and can successfully deliver these drugs to specific sites in vivo. Moreover, when these IO-NC are coated with a lung-tropic exosome, it can effectively target and treat lung metastasis due to breast cancer.

Symposium Organizers

Don Futaba, National Institute of Advanced Industrial Science and Technology
Alister Page, The University of Newcastle, Australia
Ranjit Pati, Michigan Technological University
Ming Xu, Huazhong University of Science and Technology

Symposium Support

Bronze
MilliporeSigma

Publishing Alliance

MRS publishes with Springer Nature